S1PR2 and Alzheimer disease: The topical application of JTE-013, an S1PR2 antagonist (Figure 3b and Figure 4b), was able to significantly reduce inflammation and mast cell accumulation in skin tissues of 2,4-dinitrochlorobenzene (DNCB)-induced AD mouse models, suggesting it as a potential therapeutic agent in AD patients [121].